Matches in Nanopublications for { ?s ?p "[Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1166359.RAg1PLMkIqmUAPWck6DLs9Z12xpH5a4-EHEvidzqegzsc130_assertion description "[Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1166359.RAg1PLMkIqmUAPWck6DLs9Z12xpH5a4-EHEvidzqegzsc130_provenance.
- NP1166361.RApaj1cljtatxC39UgOdMGLjX9E-HA-p6XjkjwJWCBB5A130_assertion description "[Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1166361.RApaj1cljtatxC39UgOdMGLjX9E-HA-p6XjkjwJWCBB5A130_provenance.
- NP973146.RAIWprdcyNbhwRSW1StcPUAPQY6UIpP3T2GlaAGjgg6aA130_assertion description "[Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973146.RAIWprdcyNbhwRSW1StcPUAPQY6UIpP3T2GlaAGjgg6aA130_provenance.
- NP1166360.RANS7SQ5gpbpH893Nn1V1AuNUlw9Lk7VZdU2uXoG5Hiyw130_assertion description "[Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1166360.RANS7SQ5gpbpH893Nn1V1AuNUlw9Lk7VZdU2uXoG5Hiyw130_provenance.
- NP973070.RAw7SEX32SJ6VA-L-gJM9imCrBZy63sM8M-TUeOQSxevs130_assertion description "[Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973070.RAw7SEX32SJ6VA-L-gJM9imCrBZy63sM8M-TUeOQSxevs130_provenance.
- NP973106.RA-0xO1xYyYIk3VYJWOIwxdbGxY-Wj0QDA7_BU60vC57E130_assertion description "[Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973106.RA-0xO1xYyYIk3VYJWOIwxdbGxY-Wj0QDA7_BU60vC57E130_provenance.